Timely Data Resources | 8 pages | January 2007 | English
The Alzheimer's Dementia Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments.
Partneringdesk deals and alliances in central nervous system diseases provides an in-depth view of over 1100 deals and alliances announced in central nervous system diseases between 2001 and 2006, in ...
IntroductionWith annual revenues of over $2.6 billion in 2004, and a compound annual growth rate of 36.7% since 2002, the ADHD market is one of the most rapidly growing CNS markets. This growth is ...
IntroductionGastroesophageal reflux disease (GERD), functional dyspepsia (FD) and peptic ulcer disease (PUD) represent a group of common gastrointestinal (GI) conditions, which can be referred to coll ...
With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech in ...
Psychiatric and neurological disorders constitute as much as 35% of the disease burden in the seven major pharmaceutical markets, representing continuing opportunities for pharma companies in the CNS ...
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analys ...
IntroductionDatamonitor believes that companies developing pipeline drugs for the depression market should concentrate resources on targeting third-line depression patients, a market with significant ...
